PEPFAR’s response to the convergence of the HIV and COVID‐19 pandemics in Sub‐Saharan Africa
Introduction The COVID‐19 pandemic reached the African continent in less than three months from when the first cases were reported from mainland China. As COVID‐19 preparedness and response plans were rapidly instituted across sub‐Saharan Africa, many governments and donor organizations braced thems...
Gespeichert in:
Veröffentlicht in: | Journal of the International AIDS Society 2020-08, Vol.23 (8), p.e25587-n/a |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 8 |
container_start_page | e25587 |
container_title | Journal of the International AIDS Society |
container_volume | 23 |
creator | Golin, Rachel Godfrey, Catherine Firth, Jacqueline Lee, Lana Minior, Thomas Phelps, B Ryan Raizes, Elliot G Ake, Julie A Siberry, George K |
description | Introduction
The COVID‐19 pandemic reached the African continent in less than three months from when the first cases were reported from mainland China. As COVID‐19 preparedness and response plans were rapidly instituted across sub‐Saharan Africa, many governments and donor organizations braced themselves for the unknown impact the COVID‐19 pandemic would have in under‐resourced settings with high burdens of PLHIV. The potential negative impact of COVID‐19 in these countries is uncertain, but is estimated to contribute both directly and indirectly to the morbidity and mortality of PLHIV, requiring countries to leverage existing HIV care systems to propel COVID‐19 responses, while safeguarding PLHIV and HIV programme gains. In anticipation of COVID‐19‐related disruptions, PEPFAR promptly established guidance to rapidly adapt HIV programmes to maintain essential HIV services while protecting recipients of care and staff from COVID‐19. This commentary reviews PEPFAR’s COVID‐19 technical guidance and provides country‐specific examples of programme adaptions in sub‐Saharan Africa.
Discussion
The COVID‐19 pandemic may pose significant risks to the continuity of HIV services, especially in countries with high HIV prevalence and weak and over‐burdened health systems. Although there is currently limited understanding of how COVID‐19 affects PLHIV, it is imperative that public health systems and academic centres monitor the impact of COVID‐19 on PLHIV. The general principles of the HIV programme adaptation guidance from PEPFAR prioritize protecting the gains in the HIV response while minimizing in‐person home and facility visits and other direct contact when COVID‐19 control measures are in effect. PEPFAR‐supported clinical, laboratory, supply chain, community and data reporting systems can play an important role in mitigating the impact of COVID‐19 in sub‐Saharan Africa.
Conclusions
As community transmission of COVID‐19 continues and the number of country cases rise, fragile health systems may be strained. Utilizing the adaptive, data‐driven programme approaches in facilities and communities established and supported by PEPFAR provides the opportunity to strengthen the COVID‐19 response while protecting the immense gains spanning HIV prevention, testing and treatment reached thus far. |
doi_str_mv | 10.1002/jia2.25587 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7405155</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A720275456</galeid><sourcerecordid>A720275456</sourcerecordid><originalsourceid>FETCH-LOGICAL-c7177-670f5230dc6e86ae4ec40cf20d837500ffdad1e2d4df2cd6b5c8adf0091f9dab3</originalsourceid><addsrcrecordid>eNqNksFuEzEQhlcIREvhwgMgS0gIISXY3rW9e6kUhZYGVWpFoVfLscfJRhs72LtFvfURuPJ6fRKcpJQERVXlg-3xN__Ynj_LXhPcJxjTj7Na0T5lrBRPsn0iWNmjnNGnG-u97EWMM4w5LYvqebaXU8GFwGI_G58fnR8Pvt7e_I4oQFx4FwG1HrVTQNq7KwgTcBqQt6vQyegSKWfQ8Oxy9On25hep0CLtYV7riGqHLrpxil6oqQrKoYENtVYvs2dWNRFe3c0H2ffjo2_Dk97p2efRcHDa04II0eMCW0ZzbDSHkisoQBdYW4pNmQuGsbVGGQLUFMZSbfiY6VIZi3FFbGXUOD_IDte6i248B6PBtUE1chHquQrX0qtabp-4eion_kqKAjPCWBJ4fycQ_I8OYivnddTQNMqB76KkRU5KynNBE_r2P3Tmu-DS85aUSP9e5uQfNVENyNpZn-rqpagcCIqpYAXjD1I8L3lOaFElqreDSs2B9BTvwNYpvKX6GH5Tv7-DT2PV3J0FHpWwWeHdRsIUVNNOo2-6tk6m2wY_rEEdfIwB7H0PCZZLx8ul4-XK8Ql-s9n1e_SvxRNA1sDPdJ_rB6Tkl9GArkX_AMcGCBg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2437758831</pqid></control><display><type>article</type><title>PEPFAR’s response to the convergence of the HIV and COVID‐19 pandemics in Sub‐Saharan Africa</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Golin, Rachel ; Godfrey, Catherine ; Firth, Jacqueline ; Lee, Lana ; Minior, Thomas ; Phelps, B Ryan ; Raizes, Elliot G ; Ake, Julie A ; Siberry, George K</creator><creatorcontrib>Golin, Rachel ; Godfrey, Catherine ; Firth, Jacqueline ; Lee, Lana ; Minior, Thomas ; Phelps, B Ryan ; Raizes, Elliot G ; Ake, Julie A ; Siberry, George K</creatorcontrib><description>Introduction
The COVID‐19 pandemic reached the African continent in less than three months from when the first cases were reported from mainland China. As COVID‐19 preparedness and response plans were rapidly instituted across sub‐Saharan Africa, many governments and donor organizations braced themselves for the unknown impact the COVID‐19 pandemic would have in under‐resourced settings with high burdens of PLHIV. The potential negative impact of COVID‐19 in these countries is uncertain, but is estimated to contribute both directly and indirectly to the morbidity and mortality of PLHIV, requiring countries to leverage existing HIV care systems to propel COVID‐19 responses, while safeguarding PLHIV and HIV programme gains. In anticipation of COVID‐19‐related disruptions, PEPFAR promptly established guidance to rapidly adapt HIV programmes to maintain essential HIV services while protecting recipients of care and staff from COVID‐19. This commentary reviews PEPFAR’s COVID‐19 technical guidance and provides country‐specific examples of programme adaptions in sub‐Saharan Africa.
Discussion
The COVID‐19 pandemic may pose significant risks to the continuity of HIV services, especially in countries with high HIV prevalence and weak and over‐burdened health systems. Although there is currently limited understanding of how COVID‐19 affects PLHIV, it is imperative that public health systems and academic centres monitor the impact of COVID‐19 on PLHIV. The general principles of the HIV programme adaptation guidance from PEPFAR prioritize protecting the gains in the HIV response while minimizing in‐person home and facility visits and other direct contact when COVID‐19 control measures are in effect. PEPFAR‐supported clinical, laboratory, supply chain, community and data reporting systems can play an important role in mitigating the impact of COVID‐19 in sub‐Saharan Africa.
Conclusions
As community transmission of COVID‐19 continues and the number of country cases rise, fragile health systems may be strained. Utilizing the adaptive, data‐driven programme approaches in facilities and communities established and supported by PEPFAR provides the opportunity to strengthen the COVID‐19 response while protecting the immense gains spanning HIV prevention, testing and treatment reached thus far.</description><identifier>ISSN: 1758-2652</identifier><identifier>EISSN: 1758-2652</identifier><identifier>DOI: 10.1002/jia2.25587</identifier><identifier>PMID: 32767707</identifier><language>eng</language><publisher>Switzerland: International AIDS Society</publisher><subject>Acquired immune deficiency syndrome ; Acquired Immunodeficiency Syndrome - complications ; Acquired Immunodeficiency Syndrome - drug therapy ; Acquired Immunodeficiency Syndrome - epidemiology ; Acquired Immunodeficiency Syndrome - mortality ; Africa ; Africa South of the Sahara - epidemiology ; AIDS ; Betacoronavirus ; China ; Control ; Coronavirus Infections - complications ; Coronavirus Infections - drug therapy ; Coronavirus Infections - epidemiology ; Cost of Illness ; COVID-19 ; Delivery of Health Care - economics ; Delivery of Health Care - standards ; Delivery of Health Care - statistics & numerical data ; Drug therapy ; Epidemics ; Health aspects ; HIV ; HIV care continuum ; HIV infection ; HIV Infections - complications ; HIV Infections - drug therapy ; HIV Infections - epidemiology ; HIV Infections - mortality ; HIV tests ; Human immunodeficiency virus ; Humans ; International Cooperation ; Laboratories ; Mortality ; Pandemics ; PEPFAR ; Pneumonia, Viral - complications ; Pneumonia, Viral - drug therapy ; Pneumonia, Viral - epidemiology ; Political aspects ; Prevalence ; Prevention ; Public health ; readiness ; response ; SARS-CoV-2 ; Sexually transmitted disease prevention ; Sub-Saharan Africa ; Tuberculosis</subject><ispartof>Journal of the International AIDS Society, 2020-08, Vol.23 (8), p.e25587-n/a</ispartof><rights>Published 2020. This article is a U.S. Government work and is in the public domain in the USA. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of International AIDS Society.</rights><rights>COPYRIGHT 2020 International AIDS Society</rights><rights>COPYRIGHT 2020 John Wiley & Sons, Inc.</rights><rights>2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c7177-670f5230dc6e86ae4ec40cf20d837500ffdad1e2d4df2cd6b5c8adf0091f9dab3</citedby><cites>FETCH-LOGICAL-c7177-670f5230dc6e86ae4ec40cf20d837500ffdad1e2d4df2cd6b5c8adf0091f9dab3</cites><orcidid>0000-0001-6297-1222 ; 0000-0001-6883-1204 ; 0000-0001-5121-877X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405155/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405155/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1411,11541,27901,27902,45550,45551,46027,46451,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32767707$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Golin, Rachel</creatorcontrib><creatorcontrib>Godfrey, Catherine</creatorcontrib><creatorcontrib>Firth, Jacqueline</creatorcontrib><creatorcontrib>Lee, Lana</creatorcontrib><creatorcontrib>Minior, Thomas</creatorcontrib><creatorcontrib>Phelps, B Ryan</creatorcontrib><creatorcontrib>Raizes, Elliot G</creatorcontrib><creatorcontrib>Ake, Julie A</creatorcontrib><creatorcontrib>Siberry, George K</creatorcontrib><title>PEPFAR’s response to the convergence of the HIV and COVID‐19 pandemics in Sub‐Saharan Africa</title><title>Journal of the International AIDS Society</title><addtitle>J Int AIDS Soc</addtitle><description>Introduction
The COVID‐19 pandemic reached the African continent in less than three months from when the first cases were reported from mainland China. As COVID‐19 preparedness and response plans were rapidly instituted across sub‐Saharan Africa, many governments and donor organizations braced themselves for the unknown impact the COVID‐19 pandemic would have in under‐resourced settings with high burdens of PLHIV. The potential negative impact of COVID‐19 in these countries is uncertain, but is estimated to contribute both directly and indirectly to the morbidity and mortality of PLHIV, requiring countries to leverage existing HIV care systems to propel COVID‐19 responses, while safeguarding PLHIV and HIV programme gains. In anticipation of COVID‐19‐related disruptions, PEPFAR promptly established guidance to rapidly adapt HIV programmes to maintain essential HIV services while protecting recipients of care and staff from COVID‐19. This commentary reviews PEPFAR’s COVID‐19 technical guidance and provides country‐specific examples of programme adaptions in sub‐Saharan Africa.
Discussion
The COVID‐19 pandemic may pose significant risks to the continuity of HIV services, especially in countries with high HIV prevalence and weak and over‐burdened health systems. Although there is currently limited understanding of how COVID‐19 affects PLHIV, it is imperative that public health systems and academic centres monitor the impact of COVID‐19 on PLHIV. The general principles of the HIV programme adaptation guidance from PEPFAR prioritize protecting the gains in the HIV response while minimizing in‐person home and facility visits and other direct contact when COVID‐19 control measures are in effect. PEPFAR‐supported clinical, laboratory, supply chain, community and data reporting systems can play an important role in mitigating the impact of COVID‐19 in sub‐Saharan Africa.
Conclusions
As community transmission of COVID‐19 continues and the number of country cases rise, fragile health systems may be strained. Utilizing the adaptive, data‐driven programme approaches in facilities and communities established and supported by PEPFAR provides the opportunity to strengthen the COVID‐19 response while protecting the immense gains spanning HIV prevention, testing and treatment reached thus far.</description><subject>Acquired immune deficiency syndrome</subject><subject>Acquired Immunodeficiency Syndrome - complications</subject><subject>Acquired Immunodeficiency Syndrome - drug therapy</subject><subject>Acquired Immunodeficiency Syndrome - epidemiology</subject><subject>Acquired Immunodeficiency Syndrome - mortality</subject><subject>Africa</subject><subject>Africa South of the Sahara - epidemiology</subject><subject>AIDS</subject><subject>Betacoronavirus</subject><subject>China</subject><subject>Control</subject><subject>Coronavirus Infections - complications</subject><subject>Coronavirus Infections - drug therapy</subject><subject>Coronavirus Infections - epidemiology</subject><subject>Cost of Illness</subject><subject>COVID-19</subject><subject>Delivery of Health Care - economics</subject><subject>Delivery of Health Care - standards</subject><subject>Delivery of Health Care - statistics & numerical data</subject><subject>Drug therapy</subject><subject>Epidemics</subject><subject>Health aspects</subject><subject>HIV</subject><subject>HIV care continuum</subject><subject>HIV infection</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - epidemiology</subject><subject>HIV Infections - mortality</subject><subject>HIV tests</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>International Cooperation</subject><subject>Laboratories</subject><subject>Mortality</subject><subject>Pandemics</subject><subject>PEPFAR</subject><subject>Pneumonia, Viral - complications</subject><subject>Pneumonia, Viral - drug therapy</subject><subject>Pneumonia, Viral - epidemiology</subject><subject>Political aspects</subject><subject>Prevalence</subject><subject>Prevention</subject><subject>Public health</subject><subject>readiness</subject><subject>response</subject><subject>SARS-CoV-2</subject><subject>Sexually transmitted disease prevention</subject><subject>Sub-Saharan Africa</subject><subject>Tuberculosis</subject><issn>1758-2652</issn><issn>1758-2652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNksFuEzEQhlcIREvhwgMgS0gIISXY3rW9e6kUhZYGVWpFoVfLscfJRhs72LtFvfURuPJ6fRKcpJQERVXlg-3xN__Ynj_LXhPcJxjTj7Na0T5lrBRPsn0iWNmjnNGnG-u97EWMM4w5LYvqebaXU8GFwGI_G58fnR8Pvt7e_I4oQFx4FwG1HrVTQNq7KwgTcBqQt6vQyegSKWfQ8Oxy9On25hep0CLtYV7riGqHLrpxil6oqQrKoYENtVYvs2dWNRFe3c0H2ffjo2_Dk97p2efRcHDa04II0eMCW0ZzbDSHkisoQBdYW4pNmQuGsbVGGQLUFMZSbfiY6VIZi3FFbGXUOD_IDte6i248B6PBtUE1chHquQrX0qtabp-4eion_kqKAjPCWBJ4fycQ_I8OYivnddTQNMqB76KkRU5KynNBE_r2P3Tmu-DS85aUSP9e5uQfNVENyNpZn-rqpagcCIqpYAXjD1I8L3lOaFElqreDSs2B9BTvwNYpvKX6GH5Tv7-DT2PV3J0FHpWwWeHdRsIUVNNOo2-6tk6m2wY_rEEdfIwB7H0PCZZLx8ul4-XK8Ql-s9n1e_SvxRNA1sDPdJ_rB6Tkl9GArkX_AMcGCBg</recordid><startdate>202008</startdate><enddate>202008</enddate><creator>Golin, Rachel</creator><creator>Godfrey, Catherine</creator><creator>Firth, Jacqueline</creator><creator>Lee, Lana</creator><creator>Minior, Thomas</creator><creator>Phelps, B Ryan</creator><creator>Raizes, Elliot G</creator><creator>Ake, Julie A</creator><creator>Siberry, George K</creator><general>International AIDS Society</general><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6297-1222</orcidid><orcidid>https://orcid.org/0000-0001-6883-1204</orcidid><orcidid>https://orcid.org/0000-0001-5121-877X</orcidid></search><sort><creationdate>202008</creationdate><title>PEPFAR’s response to the convergence of the HIV and COVID‐19 pandemics in Sub‐Saharan Africa</title><author>Golin, Rachel ; Godfrey, Catherine ; Firth, Jacqueline ; Lee, Lana ; Minior, Thomas ; Phelps, B Ryan ; Raizes, Elliot G ; Ake, Julie A ; Siberry, George K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c7177-670f5230dc6e86ae4ec40cf20d837500ffdad1e2d4df2cd6b5c8adf0091f9dab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Acquired Immunodeficiency Syndrome - complications</topic><topic>Acquired Immunodeficiency Syndrome - drug therapy</topic><topic>Acquired Immunodeficiency Syndrome - epidemiology</topic><topic>Acquired Immunodeficiency Syndrome - mortality</topic><topic>Africa</topic><topic>Africa South of the Sahara - epidemiology</topic><topic>AIDS</topic><topic>Betacoronavirus</topic><topic>China</topic><topic>Control</topic><topic>Coronavirus Infections - complications</topic><topic>Coronavirus Infections - drug therapy</topic><topic>Coronavirus Infections - epidemiology</topic><topic>Cost of Illness</topic><topic>COVID-19</topic><topic>Delivery of Health Care - economics</topic><topic>Delivery of Health Care - standards</topic><topic>Delivery of Health Care - statistics & numerical data</topic><topic>Drug therapy</topic><topic>Epidemics</topic><topic>Health aspects</topic><topic>HIV</topic><topic>HIV care continuum</topic><topic>HIV infection</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - epidemiology</topic><topic>HIV Infections - mortality</topic><topic>HIV tests</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>International Cooperation</topic><topic>Laboratories</topic><topic>Mortality</topic><topic>Pandemics</topic><topic>PEPFAR</topic><topic>Pneumonia, Viral - complications</topic><topic>Pneumonia, Viral - drug therapy</topic><topic>Pneumonia, Viral - epidemiology</topic><topic>Political aspects</topic><topic>Prevalence</topic><topic>Prevention</topic><topic>Public health</topic><topic>readiness</topic><topic>response</topic><topic>SARS-CoV-2</topic><topic>Sexually transmitted disease prevention</topic><topic>Sub-Saharan Africa</topic><topic>Tuberculosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Golin, Rachel</creatorcontrib><creatorcontrib>Godfrey, Catherine</creatorcontrib><creatorcontrib>Firth, Jacqueline</creatorcontrib><creatorcontrib>Lee, Lana</creatorcontrib><creatorcontrib>Minior, Thomas</creatorcontrib><creatorcontrib>Phelps, B Ryan</creatorcontrib><creatorcontrib>Raizes, Elliot G</creatorcontrib><creatorcontrib>Ake, Julie A</creatorcontrib><creatorcontrib>Siberry, George K</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the International AIDS Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Golin, Rachel</au><au>Godfrey, Catherine</au><au>Firth, Jacqueline</au><au>Lee, Lana</au><au>Minior, Thomas</au><au>Phelps, B Ryan</au><au>Raizes, Elliot G</au><au>Ake, Julie A</au><au>Siberry, George K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PEPFAR’s response to the convergence of the HIV and COVID‐19 pandemics in Sub‐Saharan Africa</atitle><jtitle>Journal of the International AIDS Society</jtitle><addtitle>J Int AIDS Soc</addtitle><date>2020-08</date><risdate>2020</risdate><volume>23</volume><issue>8</issue><spage>e25587</spage><epage>n/a</epage><pages>e25587-n/a</pages><issn>1758-2652</issn><eissn>1758-2652</eissn><abstract>Introduction
The COVID‐19 pandemic reached the African continent in less than three months from when the first cases were reported from mainland China. As COVID‐19 preparedness and response plans were rapidly instituted across sub‐Saharan Africa, many governments and donor organizations braced themselves for the unknown impact the COVID‐19 pandemic would have in under‐resourced settings with high burdens of PLHIV. The potential negative impact of COVID‐19 in these countries is uncertain, but is estimated to contribute both directly and indirectly to the morbidity and mortality of PLHIV, requiring countries to leverage existing HIV care systems to propel COVID‐19 responses, while safeguarding PLHIV and HIV programme gains. In anticipation of COVID‐19‐related disruptions, PEPFAR promptly established guidance to rapidly adapt HIV programmes to maintain essential HIV services while protecting recipients of care and staff from COVID‐19. This commentary reviews PEPFAR’s COVID‐19 technical guidance and provides country‐specific examples of programme adaptions in sub‐Saharan Africa.
Discussion
The COVID‐19 pandemic may pose significant risks to the continuity of HIV services, especially in countries with high HIV prevalence and weak and over‐burdened health systems. Although there is currently limited understanding of how COVID‐19 affects PLHIV, it is imperative that public health systems and academic centres monitor the impact of COVID‐19 on PLHIV. The general principles of the HIV programme adaptation guidance from PEPFAR prioritize protecting the gains in the HIV response while minimizing in‐person home and facility visits and other direct contact when COVID‐19 control measures are in effect. PEPFAR‐supported clinical, laboratory, supply chain, community and data reporting systems can play an important role in mitigating the impact of COVID‐19 in sub‐Saharan Africa.
Conclusions
As community transmission of COVID‐19 continues and the number of country cases rise, fragile health systems may be strained. Utilizing the adaptive, data‐driven programme approaches in facilities and communities established and supported by PEPFAR provides the opportunity to strengthen the COVID‐19 response while protecting the immense gains spanning HIV prevention, testing and treatment reached thus far.</abstract><cop>Switzerland</cop><pub>International AIDS Society</pub><pmid>32767707</pmid><doi>10.1002/jia2.25587</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-6297-1222</orcidid><orcidid>https://orcid.org/0000-0001-6883-1204</orcidid><orcidid>https://orcid.org/0000-0001-5121-877X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1758-2652 |
ispartof | Journal of the International AIDS Society, 2020-08, Vol.23 (8), p.e25587-n/a |
issn | 1758-2652 1758-2652 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7405155 |
source | MEDLINE; Wiley Online Library Open Access; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Acquired immune deficiency syndrome Acquired Immunodeficiency Syndrome - complications Acquired Immunodeficiency Syndrome - drug therapy Acquired Immunodeficiency Syndrome - epidemiology Acquired Immunodeficiency Syndrome - mortality Africa Africa South of the Sahara - epidemiology AIDS Betacoronavirus China Control Coronavirus Infections - complications Coronavirus Infections - drug therapy Coronavirus Infections - epidemiology Cost of Illness COVID-19 Delivery of Health Care - economics Delivery of Health Care - standards Delivery of Health Care - statistics & numerical data Drug therapy Epidemics Health aspects HIV HIV care continuum HIV infection HIV Infections - complications HIV Infections - drug therapy HIV Infections - epidemiology HIV Infections - mortality HIV tests Human immunodeficiency virus Humans International Cooperation Laboratories Mortality Pandemics PEPFAR Pneumonia, Viral - complications Pneumonia, Viral - drug therapy Pneumonia, Viral - epidemiology Political aspects Prevalence Prevention Public health readiness response SARS-CoV-2 Sexually transmitted disease prevention Sub-Saharan Africa Tuberculosis |
title | PEPFAR’s response to the convergence of the HIV and COVID‐19 pandemics in Sub‐Saharan Africa |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T10%3A24%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PEPFAR%E2%80%99s%20response%20to%20the%20convergence%20of%20the%20HIV%20and%20COVID%E2%80%9019%20pandemics%20in%20Sub%E2%80%90Saharan%20Africa&rft.jtitle=Journal%20of%20the%20International%20AIDS%20Society&rft.au=Golin,%20Rachel&rft.date=2020-08&rft.volume=23&rft.issue=8&rft.spage=e25587&rft.epage=n/a&rft.pages=e25587-n/a&rft.issn=1758-2652&rft.eissn=1758-2652&rft_id=info:doi/10.1002/jia2.25587&rft_dat=%3Cgale_pubme%3EA720275456%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2437758831&rft_id=info:pmid/32767707&rft_galeid=A720275456&rfr_iscdi=true |